Genocea Biosciences Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
74
- Stock Symbol
-
GNCAQ
Genocea Biosciences General Information
Description
Genocea Biosciences Inc is a USA-based biopharmaceutical company discovering and developing novel cancer immunotherapies using its proprietary ATLAS platform. The ATLAS platform can profile each patient's CD4+ and CD8+ T cell immune responses to every potential target or antigen identified by next-generation sequencing of that patient's tumor. ATLAS zeroes in on both antigens that activate anti-tumor T cell responses and inhibitory antigens, or Inhibigens , that drive pro-tumor immune responses.
Contact Information
Website
www.genocea.comCorporate Office
- 100 Acorn Park Drive
- Cambridge, MA 02140
- United States
Corporate Office
- 100 Acorn Park Drive
- Cambridge, MA 02140
- United States
Genocea Biosciences Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| 480.00 |
Genocea Biosciences Financials Summary
As of 31-Mar-2022, Genocea Biosciences has a trailing 12-month revenue of $1.91M.
|
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 53,454 | 36,581 | 62,096 | 28,116 |
| Revenue | 1,911 | 1,641 | 1,359 | 0 |
| EBITDA | (34,542) | (30,518) | (41,196) | (36,907) |
| Net Income | (37,191) | (33,196) | (43,714) | (38,950) |
| Total Assets | 38,788 | 55,967 | 98,493 | 52,611 |
| Total Debt | 15,485 | 17,185 | 23,874 | 19,919 |
Genocea Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Genocea Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Genocea Biosciences Comparisons
Industry
Financing
Details
Genocea Biosciences Competitors (88)
One of Genocea Biosciences’s 88 competitors is Kite Pharma, a Formerly VC-backed company based in Santa Monica, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Cogent Biosciences | Formerly VC-backed | Waltham, MA | ||||
| RAPT Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Selecta Biosciences | Formerly VC-backed | Watertown, MA |
Genocea Biosciences Patents
Genocea Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022056491-A1 | Treatment methods | Inactive | 14-Sep-2020 | ||
| US-20210338725-A1 | Treatment methods | Inactive | 02-Apr-2020 | ||
| WO-2021203022-A1 | Treatment methods | Inactive | 02-Apr-2020 | ||
| WO-2021203022-A4 | Treatment methods | Inactive | 02-Apr-2020 | ||
| WO-2020232408-A1 | Treatment methods | Inactive | 15-May-2019 | G01N33/5047 |
Genocea Biosciences Signals
Genocea Biosciences Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Genocea Biosciences ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Genocea Biosciences FAQs
-
When was Genocea Biosciences founded?
Genocea Biosciences was founded in 2006.
-
Where is Genocea Biosciences headquartered?
Genocea Biosciences is headquartered in Cambridge, MA.
-
What is the size of Genocea Biosciences?
Genocea Biosciences has 74 total employees.
-
What industry is Genocea Biosciences in?
Genocea Biosciences’s primary industry is Drug Discovery.
-
Is Genocea Biosciences a private or public company?
Genocea Biosciences is a Public company.
-
What is Genocea Biosciences’s stock symbol?
The ticker symbol for Genocea Biosciences is GNCAQ.
-
What is Genocea Biosciences’s current revenue?
The trailing twelve month revenue for Genocea Biosciences is $1.91M.
-
Who are Genocea Biosciences’s competitors?
Kite Pharma, Adaptimmune Therapeutics, Cogent Biosciences, RAPT Therapeutics, and Selecta Biosciences are some of the 88 competitors of Genocea Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process